Inventor
AB OLGA
US20 patents
⚠️ This page may combine multiple inventors who share the name “AB OLGA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNOGEN INC
18 patentsUS9670279B2Jun 6, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC26 citations98
US9133275B2Sep 15, 2015
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC45 citations98
US10752683B2Aug 25, 2020
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC13 citations94
US10301385B2May 28, 2019
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC8 citations92
US10017578B2Jul 10, 2018
Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies
IMMUNOGEN INC12 citations92
US9670278B2Jun 6, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC18 citations92
US9670280B2Jun 6, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC19 citations92
US9657100B2May 23, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC16 citations92
US9637547B2May 2, 2017
Monoclonal antibodies for detection of folate receptor 1
IMMUNOGEN INC15 citations92
US9598490B2Mar 21, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC18 citations92
US9200073B2Dec 1, 2015
Diagnostic assays and kits for detection of folate receptor 1
IMMUNOGEN INC23 citations92
US9702881B2Jul 11, 2017
Diagnostic assays and kits for detection of folate receptor 1
IMMUNOGEN INC15 citations89
US10613093B2Apr 7, 2020
Diagnostic assays and kits for detection of folate receptor 1
IMMUNOGEN INC4 citations83
US10544230B2Jan 28, 2020
Methods of using antibodies to detect folate receptor 1 (FOLR1)
IMMUNOGEN INC4 citations83
US10180432B2Jan 15, 2019
Diagnostic assays and kits for detection of folate receptor 1
IMMUNOGEN INC6 citations83
US11198736B2Dec 14, 2021
Method for identifying an ovarian cancer in a subject likely to respond to anti-folate receptor 1 (FOLR1) antibody
IMMUNOGEN INC5 citations81
US11932701B2Mar 19, 2024
Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate
IMMUNOGEN INC1 citations72
US11834498B2Dec 5, 2023
Biparatopic FR-alpha antibodies and immunoconjugates
IMMUNOGEN INC2 citations72